kinases protein kinase inhibitors signaling activators kinase substrates antibodies bioluminescence assays
Recombinant human CD62E / E-Selectin Protein, His tag, 200µg  

Recombinant human CD62E / E-Selectin Protein, His tag, 200µg

Recombinant Human CD62E / E-Selectin Protein (Trp22-Pro556), produced in human 293 cells (HEK293), His tag

Recombinant human protein, SELE, RP1-117P20.2, CD62E, ELAM1, ESEL, LECAM2, E-Selectin

More details


Availability: within 7 days

390,00 €

E-Selectin, also known as CD62 antigen-like family member E (CD62E), endothelial-leukocyte adhesion molecule 1 (ELAM-1), or leukocyte-endothelial cell adhesion molecule 2 (LECAM2), a member of the Selectin family, is a 107-115 kDa cell surface glycoprotein.[1] It is transiently expressed on vascular endothelial cells in response to IL-1β and TNFα. E selectin has a cassette structure: an N-terminal, C-type lectin domain, an EGF (epidermal-growth-factor)-like domain, 6 Sushi domain (SCR repeat) units, a transmembrane domain (TM) and an intracellular cytoplasmic tail (cyto).[2] During inflammation, E-selectin plays an important part in recruiting leukocytes to the site of injury. The local release of cytokines IL-1 and TNF-α by damaged cells induces the over-expression of E-selectin on endothelial cells of nearby blood vessels.[3] E-selectin mediates the adhesion of tumor cells to endothelial cells, by binding to E-selectin ligands expressed by neutrophils, monocytes, eosinophils, memory-effector T-like lymphocytes, natural killer cells or cancer cells. Furthermore, a number of studies have reported that levels of E-Selectin may be elevated in subjects with a variety of pathological conditions.

Recombinant Human CD62E /E-Selectin Protein (rhCD62E), His Tag (CDE-H5222) is expressed from human 293 cells (HEK293). It contains AA Trp 22 - Pro 556 (Accession # NP_000441.2).
Predicted N-terminus: Trp 22

Molecular Characterization
This protein carries a polyhistidine tag at the C-terminus.
The protein has a calculated MW of 59.5 kDa. The protein migrates as 67-96 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.

Less than 1.0 EU per μg by the LAL method.

>95% as determined by SDS-PAGE.

Lyophilized from 0.22 μm filtered solution in PBS, pH7.4. Normally trehalose is added as protectant before lyophilization.

See Certificate of Analysis for details of reconstitution instruction and specific concentration.

For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
-20°C to -70°C for 12 months in lyophilized state;
-70°C for 3 months under sterile conditions after reconstitution.

Clinical and Translational Updates

(1) "E-selectin-targeting lipid nanoparticles improve therapeutic efficacy and reduce side effects of bortezomib in multiple myeloma"
Maksimos, Muz, Magnani et al
Blood Cancer J (2023) 13 (1), 48
(2) "Cord blood transforming growth factor-β-induced as predictive biomarker of retinopathy of prematurity in preterm infants"
Song, Woo, Park et al
Graefes Arch Clin Exp Ophthalmol (2023)
(3) "Associations of Microvascular Injury-Related Biomarkers with Traumatic Brain Injury Severity and Outcomes: A TRACK-TBI Pilot Study"
Christman Schneider, Huie, Jain et al
J Neurotrauma (2023)
Showing 1-3 of 9604 papers.